Dermacell is not a procedure that places living stem cells. It is a name for hADM (human acellular dermal matrix) made by removing cells from donated human skin. Even if it appears alongside stem cells in search results, the first point to confirm in consultation is whether cells are present in today’s sheet or syringe.
The materials this name can refer to
Dermacell, confirmed overseas as a product name, is a surgical sheet that places a remaining support structure of collagen and elastin onto the operative site after cells have been removed from donated dermis. The author of the paper that described this processing method is affiliated with the organization that handles that material. The clinic procedure name Dermacell is confirmed by the product name on the product documents used that day.
| Name used | Material actually used | Form on the day |
|---|---|---|
| Dermacell | Matrix from donated dermis with the cells removed | Surgical sheet |
| Clinic procedure name Dermacell | Has a separate product name | Confirm in the product documents |
| SVF | Mixed cells collected from your own fat on the same day | Applied the same day after harvest |
International societies describe SVF (stromal vascular fraction) obtained directly from fat as a different material from culture-expanded cells. SVF contains stromal cells together with vascular and immune-lineage cells. Among the authors of this joint statement are researchers with advisory or founding histories at cell-related companies. The pathway of collecting from fat continues in the SVF procedure guide, and human dermis minced for injection continues in the Re2O skin booster guide.
Sheet or injection: what splits on the day
Even when the same name is used, what is done that day diverges. If a sheet is placed, you hear about surgical anesthesia and how it is fixed; if it is injected, you hear about the layer and what is mixed in. PRF, which makes fibrin from your own blood, starts with a blood draw. The consent form records whether the material is donated dermis, your own fat, or your own blood. Materials prepared from blood are aligned with the PRF procedure guide.
| Form | What is done that day | What to hear in advance |
|---|---|---|
| Surgical sheet | Covers or reinforces the site | Anesthesia, fixation method |
| Injection | Placed in portions into the planned skin layer | Injection layer, mixed ingredients |
| SVF | Fat is removed, then applied the same day | Harvest site, isolation method |
Published human records are of sheets placed in breast reconstruction and chronic wounds. Figures for a facial-injection schedule sit outside the scope of those materials. Questions to ask before using donated dermis are collected in consulting on human tissue–derived materials. Procedure composition can be checked in the Dermacell procedure information.
Immediate reactions and when to contact
Injection sites are followed by temporary redness, swelling, and bruising. Records of this sheet in breast reconstruction include seroma and infection, and the paper that compiled those cases is a small consecutive observation. If warmth spreads or fever remains, or if shortness of breath or hives appear, contact the treating clinic immediately. Shared contact criteria are aligned with the procedure safety information.
Postpone saunas and vigorous exercise until the instructed period ends. When to resume washing and makeup follows the written instructions given that day.
Questions to ask as written in consultation
The quote and consent form should list the product name of the material placed today. The international society’s patient guide recommends leaving the material’s source, expected changes, and risks in writing. Asking the items below as written separates sheet, injection, and cell materials.
- □ What today’s product name is, and whether it is material with cells removed from donated dermis
- □ Whether it is a sheet or an injection, and if an injection, what is mixed in
- □ The anesthesia method, and symptoms that warrant immediate contact besides redness and swelling
- □ Where pregnancy and breastfeeding, active infection, anticoagulants and immunosuppressants, autoimmunity, and severe allergy are written down
- □ How far application and follow-up checks are included in the quote
An explanation that groups several sites under one stem-cell label and one material is treated as a warning sign in that same guide. The difference from cultured cells is in the guide to cells obtained from fat, and the pathway presented as a skin procedure is in the stem cell skin treatment guide.
Frequently asked questions
Q1. Is Dermacell a stem cell procedure?
It is material with the cells removed from donated dermis. Leaving that day’s product name in writing keeps it from being mixed with cells collected from fat or fibrin from blood.
Q2. Does it hurt?
At a sheet site, surgical anesthesia is discussed separately. At an injection site, the anesthesia method is confirmed to match the placement depth.
Q3. How many sessions?
A sheet is applied in a single surgical site, and a method that minces the material for injection sets the session count to match the product documents.
Q4. Can it be received together with SVF or PRF?
Because the materials differ, they are not all placed on the same day. After interval and order are set, the next appointment is booked. Where the three materials sit continues in the NovaStem, SVF, and PRF comparison.
Q5. Who postpones the schedule?
If there is pregnancy or breastfeeding, active infection, anticoagulant or immunosuppressant use, autoimmunity, or a severe allergy, the schedule is booked again. Also disclose medications you take and recent facial procedures in advance.
Results, duration, and suitability vary with individual skin condition, age, and lifestyle, and the same outcome cannot be guaranteed.
Procedures may cause temporary redness or swelling, and contraindications may apply, so please confirm these during your consultation.
This article is general information and does not replace individual medical care. Please confirm diagnosis and treatment suited to your condition during a consultation.
Sources
- Moore MA et al. (2015), Cell Tissue Bank: Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review (PMID 25163609)
- LifeNet Health: DermACELL product information
- Bullocks JM et al. (2014), Eur J Plast Surg: DermACELL: a novel and biocompatible acellular dermal matrix in tissue expander and implant-based breast reconstruction (PMID 25221385)
- Bourin P et al. (2013), Cytotherapy: Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) (PMID 23570660)
- International Society for Stem Cell Research (ISSCR): Patient Handbook on Stem Cell Therapies (February 2024)
Related reading
Discuss options for your current needs
We review your current health and prior procedures before explaining appropriate options and their limits.
